Letters to the Editor

Removal of blood from laboratory mammals and birds
Whilst the recently published Joint Working Croup Report for blood sample collection provides many general rules for investigators (BVA/FRAME/RSPCA/UFAW 1993), there are several instances where strict adherence to the recommendations will result in an increased number of animals being used to obtain the same amount of data, and this is a cause for concern.
Several of the tables are not qualified by references. For example, the composite Table 3 for circulating blood volume measurements fails to note that the data are derived from variable numbers of animals per species, and that the determinations were performed by differing techniques, so that direct inter-species comparison cannot be justified. Table 4 gives no indication of the sites and anaesthetics used for the 'normal haematological' values, yet these 2 factors may have greater effects on values than age, sex and strain (which are specifically mentioned in the footnote to Table 4 ).
Civen the need to take blood sample volumes that do not cause unnecessary stress to the animals, and an agreed approximate and conservative estimate of circulating blood volume of 60 ml/kg for all species, the major concern relates to the guideline suggested for repeat blood collections, particularly with rodents. The Report suggests a maximum of 1% every 24 hours and up to 10% on a single occasion every 3-4 weeks (Section 7.2). If these recommendations are applied for a 200 g rat, this gives permitted volumes of 1.2 ml per 3-4 weeks and 120 Jll every 24 h. For pharmacology studies involving repetitive sampling, e.g. measurements of acid-base balance, where sample volumes of 150 Jll may be required at one time point, then many more animals might be required to obtain sufficient data. Similarly in 24 h period pharmacokinetic studies, the permitted volumes would present problems.
In drug safety evaluation studies, there are large unpublished historic in-house databases where blood volumes larger than those recommended appear to have had no adverse effect on animal health, whilst some studies have shown that taking relatively large volumes too frequently does affect haematological status but not apparently animal health (Cardy & Warner 1979 , Capel-Edwards et 01. 1981 . For rats and mice, some laboratories have routinely collected blood for haematological investigations followed by a 7-10 day interval before collecting a further sample for biochemical measurements and a subsequent 2-3 month period before the next blood collection. If the report's recommendations were rigidly applied, these schedules would not be possible and it would be necessary to use more animals to provide the data required by regulatory authorities. The greater inter-animal variation would also make the data less reliable. It would seem more logical to apply the same maximum volume for single blood collections to repetitive blood collections taken within a 3-4 week period; this would allow larger individual samples but still limit the total to a reasonable level. The Joint Working Croup appear to have moved from the recommendations made by McCuill & Rowan (1989), who suggested that investigators limit (1) blood sampling to 15% of total blood volume for a single sampling, and (21 7.5% as a weekly limit for repetitive blood sampling in the absence of any further scientific data. It would seem advisable to clarify the situation particularly for repetitive blood collection schedules, where the suggestions of McCuill & Rowan may be preferable. For laboratory animals where the body weight exceeds 1 kg, the recommendations present fewer problems than when applied to smaller rodents.
It seems odd that the only details for a bloodcollecting procedure given in the Report relate to retro-orbital sinus blood collections, when the Report suggests that this technique is not recommended for use with recovery (Section 3.4 and Appendix). Most investigators would agree that this technique requires skill, and the provision of technical detail for the method may help the individual investigator, but given a non-recovery situation there are plenty of other, and perhaps more suitable, blood collection sites available to the investigator. The retro-orbital site may be an invaluable alternative site in studies where the tail is being used for intravenous injections of xenobiotics.
In Section 3.3.6, the ratio of blood to sodium citrate solution quoted will be incorrect for many coagulation studies, e.g. prothrombin time (Hall & Malia 1991), and the concentration quoted for heparin will not be the same for lithium heparin, which is more commonly used. Investigators should check with their local laboratories as to the correct anticoagulants required for particular tests.
Technical developments during the last decade have reduced the volumes required for the common haematological and biochemical analyses but some assays such as hormones and xenobiotics still require relatively large volumes of blood. Several problems may arise when very small samples are taken during rodent studies. Firstly, the variability between samples is increased, and it is possible to show that haematological values may differ markedly when taking repetitive small samples rather than one larger sample. Contamination effects due to tissue fluids are increased in small volume samples. Sample evaporation during Laboratory Animals (1994) In summary, some of these recommendations need to be debated further before their universal and rigid application. Some of the suggestions are based on an inadequate database and, rather than several investigators conducting independent studies, I suggest there may be a need for recognized carefully sponsored studies to provide a more scientific basis for discussion.
G The Report's authors reply:
Evans raises several points regarding the First Report from the Joint Working Group on Refinement. His two main concerns are that the Report would be interpreted as a definitive 'code of practice' and that the recommendations, if strictly applied, would result in an increase in animal use. We would like to stress that the aim of this document is to provide guidelines to help those removing blood from animals do so in a humane way. We hoped it would make people more aware of the general principles that should be considered when removing blood, and that it would thus be useful as basic reading for personal licensee training and when drawing up project licences. Evans's understandable desire to reduce the number of animals used is laudable, but this may not be in the best interest of either the individual animal or the science. The 1986 Animals (Scientific Procedures) Act requires that suffering imposed on an animal should be kept to a minimum. To comply with this and ensure that the suffering of individuals is minimized, an increased number of animals may be used. Judgements on such matters are legally made by the project licence applicant and the Home Office Inspector (and advisers), although others (the named persons, the personal licensees) may also contribute their views. In the case of blood sampling, a judgement is made on whether the level of stress caused by repeated bleeding of a single animal is sufficiently high to warrant using a second or third animal instead. The added variance has, of course, also to be taken into account. From a scientific viewpoint, the stress of repeated blood sampling and the consequent dilution of blood parameters may be of more concern than using more than one animal. For example, effete glycoproteins are removed from the circulation more rapidly than newly synthesized molecules. Thus the removal of blood will increase the proportion of new to old glycoproteins and this might affect drug binding studies. We hoped our report would help in making such decisions.
Evans also raises a number of specific points, some of which are based on unpublished in-house data. Therein lies one obvious problemj we can only scrutinize what is published. It is also clearly impossible in a report such as this to give sufficiently detailed information to allow for every experimental protocol. The variations in the number of bleeds, volume of blood withdrawn, the species, sites and anaesthetics would have made the tables totally indigestible.
Refinement is an ongoing process dependent on information currently available. Our Report aimed to stimulate discussion and/or future studies which would lead to further improvements. We hope this correspondence will be seen in this context. 
